These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26868826)

  • 1. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention.
    Tenekecioglu E; Farooq V; Bourantas CV; Silva RC; Onuma Y; Yılmaz M; Serruys PW
    BMC Cardiovasc Disord; 2016 Feb; 16():38. PubMed ID: 26868826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
    Wiebe J; Nef HM; Hamm CW
    J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies].
    Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Intervention: From Angioplasty to Bioresorbable Vascular Scaffold.
    Du F; Zhou J
    Adv Exp Med Biol; 2018; 1097():181-189. PubMed ID: 30315545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
    Cassese S; Byrne RA; Ndrepepa G; Kufner S; Wiebe J; Repp J; Schunkert H; Fusaro M; Kimura T; Kastrati A
    Lancet; 2016 Feb; 387(10018):537-544. PubMed ID: 26597771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioresorbable vascular scaffold in patients with complex coronary artery disease.
    Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioresorbable Scaffolds for Coronary Artery Disease.
    Nathan A; Kobayashi T; Kolansky DM; Wilensky RL; Giri J
    Curr Cardiol Rep; 2017 Jan; 19(1):5. PubMed ID: 28108898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications.
    Bourantas CV; Onuma Y; Farooq V; Zhang Y; Garcia-Garcia HM; Serruys PW
    Int J Cardiol; 2013 Jul; 167(1):11-21. PubMed ID: 22748288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Rizik DG; Hermiller JB; Kereiakes DJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioresorbable magnesium scaffold (Magmaris)-State of the art: From basic concept to clinical application.
    Rola P; Włodarczak S; Doroszko A; Lesiak M; Włodarczak A
    Catheter Cardiovasc Interv; 2022 Nov; 100(6):1051-1058. PubMed ID: 36229949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary bioresorbable vascular scaffolds: requiescant in pace?
    Alfonso F; Cuesta J; Rivero F
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):569-572. PubMed ID: 33622635
    [No Abstract]   [Full Text] [Related]  

  • 17. Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.
    Sorrentino S; Giustino G; Mehran R; Kini AS; Sharma SK; Faggioni M; Farhan S; Vogel B; Indolfi C; Dangas GD
    J Am Coll Cardiol; 2017 Jun; 69(25):3055-3066. PubMed ID: 28412389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.
    Dziewierz A; Dudek D
    Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioresorbable vascular scaffolds: design, clinical trials, and current applications.
    Devito F; Zito A; Dachille A; Carbonara R; Giardinelli F; Bulzis G; Navarese EP; Scicchitano P; Gaglione A; Masi F; Ciccone MM
    Coron Artery Dis; 2016 Mar; 27(2):151-8. PubMed ID: 26717005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.